Drugs and Cell Therapies in Hematology

Show Articles
Journal Properties
  • Number of Articles
    91
  • Abbreviation
    Drugs Cell Ther Hematol
  • ISSN
    2281-4884
  • e-ISSN
    2281-4876
  • Publisher
    PAGEPress Publications
  • Indian UGC
  • DOAJ (latest)
Description
_Drugs and Cell Therapies in Hematology_ is a peer-reviewed journal dedicated to advancing the understanding and treatment of hematological disorders through innovative pharmacological and cellular therapies. It serves as a platform for researchers and clinicians to share groundbreaking findings and insights in this rapidly evolving field. The journal's scope encompasses a wide array of topics, including novel drug development, clinical trials, cell-based therapies (such as stem cell transplantation and immunotherapy), and the molecular mechanisms underlying hematological malignancies and benign hematologic conditions. Coverage extends to areas like leukemia, lymphoma, myeloma, and other blood disorders, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Indexed in major databases, this journal ensures global visibility and accessibility of its published research. Researchers, hematologists, oncologists, and other healthcare professionals can leverage this resource to stay informed about the latest therapeutic strategies. Authors are encouraged to contribute their original research to further enhance the journal's impact on improving patient outcomes in hematology.